ATE148454T1 - Neuen vitamin d derivate - Google Patents

Neuen vitamin d derivate

Info

Publication number
ATE148454T1
ATE148454T1 AT94903741T AT94903741T ATE148454T1 AT E148454 T1 ATE148454 T1 AT E148454T1 AT 94903741 T AT94903741 T AT 94903741T AT 94903741 T AT94903741 T AT 94903741T AT E148454 T1 ATE148454 T1 AT E148454T1
Authority
AT
Austria
Prior art keywords
pct
compounds
thiol
sec
derivatives
Prior art date
Application number
AT94903741T
Other languages
English (en)
Inventor
Gunnar Grue-Sorensen
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE148454T1 publication Critical patent/ATE148454T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94903741T 1992-12-23 1993-12-17 Neuen vitamin d derivate ATE148454T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226877A GB9226877D0 (en) 1992-12-23 1992-12-23 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE148454T1 true ATE148454T1 (de) 1997-02-15

Family

ID=10727157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94903741T ATE148454T1 (de) 1992-12-23 1993-12-17 Neuen vitamin d derivate

Country Status (15)

Country Link
US (1) US5554599A (de)
EP (1) EP0675878B1 (de)
KR (1) KR100295977B1 (de)
AT (1) ATE148454T1 (de)
AU (1) AU668638B2 (de)
CA (1) CA2146775C (de)
DE (1) DE69307929T2 (de)
DK (1) DK0675878T3 (de)
ES (1) ES2098123T3 (de)
FI (1) FI108225B (de)
GB (1) GB9226877D0 (de)
GR (1) GR3022774T3 (de)
NZ (1) NZ259317A (de)
RU (1) RU2136660C1 (de)
WO (1) WO1994014766A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
ATE195513T1 (de) * 1994-04-11 2000-09-15 Chugai Pharmaceutical Co Ltd 22-thiavitamin-d3-derivate
US6869940B2 (en) 1995-12-28 2005-03-22 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
AU1152997A (en) * 1995-12-28 1997-07-28 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) * 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
DK0947504T3 (da) * 1996-12-20 2003-11-24 Chugai Pharmaceutical Co Ltd 16-en-vitamin D-derivater
US6184398B1 (en) 1996-12-20 2001-02-06 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin D derivatives
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
EP1745787B1 (de) 1999-04-01 2016-11-09 Johns Hopkins University NICHT-CALCEMISCHE, TRANSKRIPTIONELL-AKTIVE, SCHWEFELHALTIGE ANALOGA VON 1-alpha, 25-DIHYDROXYVITAMIN D3 MIT ANTIPROLIFERATIVER WIRKUNG
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
EP1275643A4 (de) * 2000-04-19 2009-06-03 Chugai Pharmaceutical Co Ltd Vitamin d derivate
IL153395A0 (en) * 2000-06-15 2003-07-06 Chugai Pharmaceutical Co Ltd Vitamin d derivatives
WO2003018545A1 (en) * 2001-08-22 2003-03-06 Johns Hopkins University 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
MXPA04003625A (es) * 2001-10-19 2004-12-02 Sotechnika Inc Sintesis de analogos de ciclosporina.
US7101865B2 (en) 2002-06-13 2006-09-05 Cytochroma Inc. 24-sulfoximine vitamin D3 compounds
US8106035B2 (en) 2002-12-18 2012-01-31 Cytochroma Inc. 25-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3
CA2981549A1 (en) 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN106265695B (zh) 2009-08-14 2021-05-07 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) * 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
SU1445729A1 (ru) * 1986-04-08 1988-12-23 Харьковский научно-исследовательский институт дерматологии и венерологии Способ лечени псориаза
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
ATE195513T1 (de) * 1994-04-11 2000-09-15 Chugai Pharmaceutical Co Ltd 22-thiavitamin-d3-derivate

Also Published As

Publication number Publication date
KR100295977B1 (ko) 2001-11-14
DE69307929T2 (de) 1997-09-04
RU95113480A (ru) 1997-03-20
FI952972A0 (fi) 1995-06-16
FI952972L (fi) 1995-06-16
WO1994014766A1 (en) 1994-07-07
KR950703501A (ko) 1995-09-20
DE69307929D1 (de) 1997-03-13
GR3022774T3 (en) 1997-06-30
EP0675878A1 (de) 1995-10-11
AU5808794A (en) 1994-07-19
GB9226877D0 (en) 1993-02-17
NZ259317A (en) 1997-05-26
CA2146775C (en) 2005-06-28
AU668638B2 (en) 1996-05-09
US5554599A (en) 1996-09-10
RU2136660C1 (ru) 1999-09-10
CA2146775A1 (en) 1994-07-07
ES2098123T3 (es) 1997-04-16
FI108225B (fi) 2001-12-14
DK0675878T3 (da) 1997-04-28
EP0675878B1 (de) 1997-01-29

Similar Documents

Publication Publication Date Title
DE69307929D1 (de) Neuen vitamin d derivate
Bahrami et al. Direct conversion of thiols and disulfides into sulfonamides
ATE138069T1 (de) Schwefel enthaltende kondensierte pyrimidinderivate, ihre herstellung und verwendung
NO930974L (no) Fremstilling og anvendelse av triazolpyridazinforbindelser
ATE37180T1 (de) 1-carbonyl-1-phenyl-2-azolyl-ethanol derivate als mikrobizide und wuchsregulatoren, sowie ihre zwischenprodukte.
KR870005995A (ko) 피리(미)딜-옥시-및-티오-벤조산 유도체의 제조 방법
ES2180201T3 (es) Derivados de azetidinona para el tratamiento de infecciones por hcmv.
SU633479A3 (ru) Способ получени стильбеновых соединений
ES514618A0 (es) "procedimiento para la preparacion de derivados de arilamina".
ATE116650T1 (de) Sulfonylamin substituierte bizyklische hydroxansäurederivate.
JPS5681578A (en) Novel thioalkyl amide derivative
EP0424194A2 (de) Benzanilidederivate und Ihre Verwendung als anti-atherosclerosis Wirkstoffe
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
DK0612310T3 (da) Fremgangsmåde til fremstilling af kanelsyrederivater
US2467895A (en) Piperazine derivatives and method of preparing the same
HU199113B (en) Process for production of new derivatives of 2,3-diamin-acryl-acid-nitril
GB2023579A (en) Methanimidamidyl cystamines
KR850001173A (ko) 2-치환된 4-페닐이미다졸 아미딘 유도체의 제조방법
ES8403888A1 (es) Un procedimiento para la preparacion de un 1h- o 2h-tetrazol-5-tiol.
ATE162191T1 (de) Azanoradamantane
CN110437114A (zh) 一种合成不对称氰基烷基二硫醚的方法
AU6520698A (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
ES8200092A1 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
Uttosen 22-Thio vitamin D derivatives
SU698511A3 (ru) Гербицидна композици

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee